Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jun 3;316(6):329.
doi: 10.1007/s00403-024-03003-2.

Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial

Affiliations
Randomized Controlled Trial

Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial

Parikesit Muhammad et al. Arch Dermatol Res. .

Abstract

Dry skin is a common dermatological condition that frequently affects the elderly. A contributing cause to dry skin is a reduced concentration of hyaluronic acid (HA) in both the epidermis and dermis. The effectiveness of moisturizer containing HA as a therapy for dry skin is impacted by its specific molecular weight. Low molecular weight HA (LMWHA) is believed to be more effective in replenishing skin hydration in aging skin compared to High Molecular Weight HA (HMWHA) due to its ability to penetrate the stratum corneum. However, there is a lack of clinical research supporting this claim. A double-blind, randomized controlled trial was conducted on 36 residents of a nursing home in Jakarta. The participants, aged between 60 and 80 years, had been diagnosed with dry skin. Each test subject was administered three distinct, randomized moisturizing lotions (LMWHA, HMWHA, or vehicle), to be topically applied to three separate sites on the leg. Skin capacitance (SCap), transepidermal water loss (TEWL), and specified symptom sum score (SRRC) were measured at weeks 0, 2, and 4. After four weeks of therapy, area that was treated with LMWHA showed greater SCap values compared to the area treated with HMWHA (56.37 AU vs. 52.37 AU, p = 0.004) and vehicle (56.37 AU vs. 49.01 AU, p < 0.001). All groups did not show any significant differences in TEWL and SRRC scores. No side effects were found in all groups. The application of a moisturizer containing LMWHA to the dry skin of elderly resulted in significant improvements in skin hydration compared to moisturizers containing HMWHA and vehicle. Furthermore, these moisturizers demonstrated similar safety in treating dry skin in the elderly. ClinicalTrials.gov Identifier NCT06178367, https://clinicaltrials.gov/study/NCT06178367 .

Keywords: Dry skin; Elderly; High molecular weight hyaluronic acid; Low molecular weight hyaluronic acid; Moisturizer; Topical.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Legiawati L, Yusharyahya SN, Sularsito SA, Setyorini ND (2017) Insidens penyakit kulit di Divisi Dermatologi Geriatri Poliklinik Kulit Dan Kelamin Rumah Sakit Dr. Cipto Mangunkusumo Tahun 2008–2013. MDVI 44(1):20–26
    1. Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M et al (2019) Diagnosis and treatment of xerosis cutis – a position paper. JDDG - J Ger Soc Dermatology 17(S7):3–33
    1. Wang Z, Man MQ, Li T, Elias PM, Mauro TM (2020) Aging-associated alterations in epidermal function and their clinical significance. Aging 12(6):5551–5565 - DOI - PubMed - PMC
    1. Bravo B, Correia P, Gonçalves Junior JE, Sant’Anna B, Kerob D (2022) Benefits of topical hyaluronic acid for skin quality and signs of skin aging: from literature review to clinical evidence. Dermatol Ther. ;1–9
    1. Lubart R, Yariv I, Fixler D, Lipovsky A (2019) Topical hyaluronic acid facial cream with new micronized molecule technology effectively penetrates and improves facial skin quality: results from In-vitro, ex-vivo, and In-vivo (Open-label) studies. J Clin Aesthet Dermatol 12(10):39–44 - PubMed - PMC

Publication types

Associated data

LinkOut - more resources